Scientific references

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

References filter

All \ A \B \C \D \E \F \G \H \I \J \K \L \M \N \O \P \Q \R \S \T \U \V \W \X \Y \Z

References to GDF-15/MIC-1 Human ELISA

  • Dostalova I, Kavalkova P, Papezova H, Domluvilova D, Zikan V, Haluzik M. Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. Nutr Metab (Lond). 2010;7:34
  • Dostalova I, Roubicek T, Bartlova M, Mraz M, Lacinova Z, Haluzikova D, Kavalkova P, Matoulek M, Kasalicky M, Haluzik M. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur J Endocrinol. 2009 Sep;161 (3):397-404
  • Stejskal D, Karpisek M, Humenanska V, Lacnak B, Svestak M. Macrophage-inhibitory cytokine-1 (mic-1) in differential diagnosis of dyspnea-A pilot study. Clin Biochem. 2009 Mar 31;

References to Ghrelin Acylated Human ELISA

  • Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004 Sep;50 (9):1511-25
  • Tvarijonaviciute A, Martinez-Subiela S, Ceron JJ. Validation of two ELISA assays for total ghrelin measurement in dogs. J Anim Physiol Anim Nutr (Berl. 2010 Dec 28;

References to Glial Fibrillary Acidic Protein Human ELISA (GFAP)

  • Brouns R, De Vil B, Cras P, De Surgeloose D, Marien P, De Deyn PP. Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke Patients. Clin Chem. 2009 Dec 3;
  • Ehrlich S, Burghardt R, Weiss D, Salbach-Andrae H, Craciun EM, Goldhahn K, Klapp BF, Lehmkuhl U. Glial and neuronal damage markers in patients with anorexia nervosa. J Neural Transm. 2008 Jun;115 (6):921-7
  • Hsu AA, Fenton K, Weinstein S, Carpenter J, Dalton H, Bell MJ. Neurological injury markers in children with septic shock. Pediatr Crit Care Med. 2008 May;9 (3):245-51
  • Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. J Alzheimers Dis. 2009 Jul;17 (3):541-51
  • Jung CS, Foerch C, Schanzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M. Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain. 2007 Dec;130 (Pt 12):3336-41
  • Kaneko T, Kasaoka S, Miyauchi T, Fujita M, Oda Y, Tsuruta R, Maekawa T. Serum glial fibrillary acidic protein as a predictive biomarker of neurological outcome after cardiac arrest. Resuscitation. 2009 Jul;80 (7):790-4
  • Kwon BK, Stammers A, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF. Cerebrospinal Fluid Inflammatory Cytokines and Biomarkers of Injury Severity in Acute Human Spinal Cord Injury. J Neurotrauma. 2009 Dec 28;
  • Linker RA, Brechlin P, Jesse S, Steinacker P, Lee DH, Asif AR, Jahn O, Tumani H, Gold R, Otto M. Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage. PLoS One. 2009;4 (10):e7624
  • Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T. Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma. 2008 Oct;65 (4):778-82; discussion 782-4
  • Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry. 2009 May;80 (5):575-7
  • Pelinka LE. Serum Markers of Severe Traumatic Brain Injury: Are They Useful?. October 15-17 (2004)
  • Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry . Nov;77(11):1284-7 (2006)
  • Ting KK, Brew BJ, Guillemin GJ. Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. J Neuroinflammation. 2009;6:36
  • Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol . Oct;13(10):1118-23 (2006)
  • Zurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien). 2011 Oct 7;

References to Glucagon-Like Peptide-1 (Active) Mouse/Rat ELISA

  • Matsui Y, Hirasawa Y, Sugiura T, Toyoshi T, Kyuki K, Ito M. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice. Biol Pharm Bull. 2010;33 (6):963-70
  • Ohara-Imaizumi M, Aoyagi K, Akimoto Y, Nakamichi Y, Nishiwaki C, Kawakami H, Nagamatsu S. Imaging exocytosis of single glucagon-like peptide-1 containing granules in a murine enteroendocrine cell line with total internal reflection fluorescent microscopy. Biochem Biophys Res Commun. 2009 Dec 4;390 (1):16-20

Pages: 1 \ 2



Shopping cart

Your cart is empty.